Results 121 to 130 of about 5,504 (241)
Exploring Small-Molecule Inhibitors of Glucosidase II: Advances, Challenges, and Therapeutic Potential in Cancer and Viral Infection. [PDF]
Oo TZM +5 more
europepmc +1 more source
Abstract The aim of this systematic review and meta‐analysis was to evaluate comprehensively the therapeutic potential of Abelmoschus esculentus (okra) supplementation across the diabetes spectrum of key metabolic risk factors. A search was conducted in PubMed, Scopus, Web of Science, EMBASE and the Cochrane Library, up to 23 July 2025, to identify ...
Ali Jafari +7 more
wiley +1 more source
Functional stratification and enzymatic arrangement in microbial communities across a hypersaline depth gradient. [PDF]
Hoepfner C +7 more
europepmc +1 more source
Cumulative Antigen Suppression Reduces Clonal Plasma Cell Evolution in Gaucher Disease
ABSTRACT Chronic antigenic stimulation is implicated in the pathogenesis of monoclonal gammopathy and multiple myeloma, yet longitudinal human evidence linking sustained antigen exposure to modifiable clonal plasma cell evolution remains limited. Gaucher disease (GD), caused by biallelic GBA1 pathogenic variants, is characterized by accumulation of ...
Noor Ul Ain +10 more
wiley +1 more source
Catalyzing Carbohydrate Cleavage: Glycosidases and Their Mechanisms. [PDF]
Overkleeft HS, Davies GJ, Williams SJ.
europepmc +1 more source
ABSTRACT Long‐chain 3‐hydroxyacyl‐CoA dehydrogenase deficiency (LCHADD) is an autosomal recessive mitochondrial defect of long‐chain fatty acid β‐oxidation, caused by biallelic pathogenic variants in HADHA or HADHB. We report a 22‐year‐old male with an atypically mild presentation of LCHADD who was referred to the Undiagnosed Diseases Network (UDN ...
Yutaka Furuta +9 more
wiley +1 more source
Glycogen and Glycosylation: Friends or Foes? [PDF]
Konada RSR, Osborn J, Mitra S.
europepmc +1 more source
Substrate specificities of glutinous rice .ALPHA.-glucosidase I and .ALPHA.-glucosidase II.
ITO, Hiroyuki +2 more
openaire +2 more sources
This prospective observational study evaluated changes in dietary patterns and body composition after 3 months of oral semaglutide treatment in people with Type 2 diabetes. Oral semaglutide was associated with reduced energy intake, salt intake and body fat while preserving handgrip strength.
Mika Sawada +9 more
wiley +1 more source

